Skip to main content
Top
Published in: Inflammation Research 10/2020

01-10-2020 | Cytokines | Short Communication

Transcriptomic analysis of hidradenitis suppurativa skin suggests roles for multiple inflammatory pathways in disease pathogenesis

Authors: Beth E. Rumberger, Erika L. Boarder, Sherry L. Owens, Michael D. Howell

Published in: Inflammation Research | Issue 10/2020

Login to get access

Abstract

Objective

Hidradenitis suppurativa (HS) is a chronic inflammatory disease with limited treatment options; therefore, the current study investigated the downstream signaling pathways that are differentially expressed in HS subjects and may drive disease pathogenesis.

Methods

The expression of 144 genes was evaluated in the skin of 16 healthy subjects and 34 subjects with mild to severe HS using QuantiGene Plex assay.

Results

One hundred and twenty-nine genes were significantly elevated in lesional HS skin as compared to the skin of healthy controls including pro-inflammatory cytokines (IL-1α, IL-6, TNF-α), IL-17-associated cytokines (IL-17A, IL-17F, IL-23A), the IL-10 family of cytokines (IL-10, IL-19, IL-20, IL-22, IL-24), and IFN family members (IFNA1, IFNB1, IFNG, IL-12B). This corresponded with increased expression of tyrosine kinases (JAK1, JAK3, BTK, SYK) and their downstream signaling partners (STAT1, STAT2, STAT3, STAT5A, STAT5B, STAT6).

Conclusion

These data illustrate the diverse immune activation in lesional HS skin and suggest that deeper interrogation of the disease heterogeneity may reveal unique opportunities for targeted therapies in designated subpopulations.
Literature
1.
go back to reference Sabat R, Jemec GBE, Matusiak L, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020;6:18.CrossRef Sabat R, Jemec GBE, Matusiak L, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020;6:18.CrossRef
2.
go back to reference Hessam S, Sand M, Gambichler T, et al. Correlation of inflammatory serum markers with disease severity in subjects with hidradenitis suppurativa (HS). J Am Acad Dermatol. 2015;73:998–1005.CrossRef Hessam S, Sand M, Gambichler T, et al. Correlation of inflammatory serum markers with disease severity in subjects with hidradenitis suppurativa (HS). J Am Acad Dermatol. 2015;73:998–1005.CrossRef
3.
go back to reference Matusiak L, Szczech J, Bieniek A, et al. Increased interleukin (IL)-17 serum levels in subjects with hidradenitis suppurativa: implications for treatment with anti-IL-17 agents. J Am Acad Dermatol. 2017;76:670–5.CrossRef Matusiak L, Szczech J, Bieniek A, et al. Increased interleukin (IL)-17 serum levels in subjects with hidradenitis suppurativa: implications for treatment with anti-IL-17 agents. J Am Acad Dermatol. 2017;76:670–5.CrossRef
4.
go back to reference Kimball AB, Okun MM, Williams DA, et al. Two phase 3 trials of adalimumab for hidradenitis suppurativa. N Engl J Med. 2016;375:422–34.CrossRef Kimball AB, Okun MM, Williams DA, et al. Two phase 3 trials of adalimumab for hidradenitis suppurativa. N Engl J Med. 2016;375:422–34.CrossRef
5.
go back to reference Scheinfeld N, Sundaram M, Teixeira H, et al. Reduction in pain scores and improvement in depressive symptoms in subjects with hidradenitis suppurativa treated with adalimumab in a phase 2, randomized, placebo-controlled trial. Dermatol Online J. 2016;22(3):2. Scheinfeld N, Sundaram M, Teixeira H, et al. Reduction in pain scores and improvement in depressive symptoms in subjects with hidradenitis suppurativa treated with adalimumab in a phase 2, randomized, placebo-controlled trial. Dermatol Online J. 2016;22(3):2.
6.
go back to reference Moran B, Sweeney CM, Hughes R, et al. Hidradenitis suppurativa is characterised by dysregulation of the Th17: Treg cell axis which is corrected by anti-TNF therapy. J Invest Dermatol. 2017;137:2389–95.CrossRef Moran B, Sweeney CM, Hughes R, et al. Hidradenitis suppurativa is characterised by dysregulation of the Th17: Treg cell axis which is corrected by anti-TNF therapy. J Invest Dermatol. 2017;137:2389–95.CrossRef
7.
go back to reference Hoffman LK, Tomalin LE, Schultz G, et al. Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and plasma cell signature. PLoS ONE. 2018;13(9):e0203672.CrossRef Hoffman LK, Tomalin LE, Schultz G, et al. Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and plasma cell signature. PLoS ONE. 2018;13(9):e0203672.CrossRef
8.
go back to reference Shanmugam VK, Jones D, McNish S, et al. Transcriptome patterns in hidradenitis suppurativa: support for the role of antimicrobial peptides and interferon pathways in disease pathogenesis. Clin Exp Derm. 2019;44:882–92.CrossRef Shanmugam VK, Jones D, McNish S, et al. Transcriptome patterns in hidradenitis suppurativa: support for the role of antimicrobial peptides and interferon pathways in disease pathogenesis. Clin Exp Derm. 2019;44:882–92.CrossRef
9.
go back to reference Zouboulis CC, Nogueira da Costa A, Makrantonaki E, et al. Alterations in innate immunity and epithelial cell differentiation are the molecular pillars of hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2020;34:846–61.CrossRef Zouboulis CC, Nogueira da Costa A, Makrantonaki E, et al. Alterations in innate immunity and epithelial cell differentiation are the molecular pillars of hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2020;34:846–61.CrossRef
10.
go back to reference Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: current and emerging treatments. J Am Acad Dermatol. 2020;82:1061–82.CrossRef Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: current and emerging treatments. J Am Acad Dermatol. 2020;82:1061–82.CrossRef
Metadata
Title
Transcriptomic analysis of hidradenitis suppurativa skin suggests roles for multiple inflammatory pathways in disease pathogenesis
Authors
Beth E. Rumberger
Erika L. Boarder
Sherry L. Owens
Michael D. Howell
Publication date
01-10-2020
Publisher
Springer International Publishing
Published in
Inflammation Research / Issue 10/2020
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-020-01381-7

Other articles of this Issue 10/2020

Inflammation Research 10/2020 Go to the issue